The Top Line cover image

The top money raisers in biotech

The Top Line

00:00

Biotech Trends and Investment Strategies

Exploring the rise of dual-track processes in biotech companies, focusing on cutting-edge technologies like AI, RNA editing, and cell therapy for autoimmune diseases. Highlighting the shift towards targeting undrugable diseases and significant financing rounds in areas like neuroscience and cardiovascular breakthroughs.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app